Patent Yard Sign in
Expired Canadian patentCanada

Methods and compositions for the early detection and treatment of insulin dependent diabetes mellitus

CA 2005300 C · Owner: Kastern, William · Inventors: Maclaren, Noel K.; Kastern, William; Atkinson, Mark A.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The subject invention concerns a novel process for the early detection of insulin dependent diabetes (IDD). The novel process described here enables the detection of the onset of IDD before clinical symptoms appear. The novel process involves the detection, in a sample of biological fluid of an , autoantibody, which is highly specific to individuals who will later develop the clinical manifestations of IDD. Novel treatments for IDD are also described.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed December 12, 1989 and granted February 15, 2000. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended December 12, 2009.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 12, 2011.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledDecember 12, 1989
GrantedFebruary 15, 2000
Term endedDecember 12, 2009
Patent numberCA 2005300 C
Classification (IPC)G01N33/56 +2 more

Timeline

Timeline From CIPO dates

1990199219941996199820002002200420062008Application filedDec 12, 1989Patent grantedFeb 15, 2000Term endedDec 12, 2009

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.